Jul. 24 at 7:10 PM
$VERV NASDAQ Equity Corporate Actions Alert #2025 - 391
(UPDATED) Information Regarding the Tender Offer of Verve Therapeutics, Inc. (VERV)
https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-391
The tender offer by Eli Lilly & Co
$LLY to acquire all of the outstanding common stock of Verve Therapeutics, Inc.
$VERV expired one minute after 11:59 p.m. ET, on July 23, 2025. The subsequent merger is tentatively scheduled to close prior to the market open on July 25, 2025. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on July 24, 2025. If the merger closes as planned, the stock will remain halted on the day of closing (July 25th) and will be suspended July 28, 2025.
Tender offer is
$10.50 & 1 Contingent Value Right (CVR) for each share of VERV held